{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:17:25Z","timestamp":1787498245867,"version":"build-2736575974"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005869","name":"University of Fribourg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005869","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In the absence of evidence from trials, individualized risk-based approaches to cancer screening among older adults have been advocated to overcome the constraints of age-based screening recommendations. According to these risk-based approaches, older adults with poor health or multimorbidity should be less frequently or not screened given a lower likelihood of benefit due to lower life expectancy. We aimed to describe colorectal, breast, cervical, and prostate cancer screening among older adults above the age of 75 according to health status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Descriptive cross-sectional study analyzing the nationwide population-based 2022 Swiss Health Survey. Self-reported cancer screening in the past 12\u00a0months was assessed according to nine indicators of health status (self-rated health, chronic condition, number of morbidities, number of medications, activities of daily living, instrumental activities of daily living, functional limitations, smoking, and body mass index) with age- and sex-adjusted prevalence ratios (aPR) using modified Poisson regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 2108 older adults were included (aged 76\u201380: 51%; women: 54%; tertiary education degree: 28%; multimorbidity (two or more morbidities): 49%; polypharmacy (five or more medications): 4%). The prevalence of any cancer screening in the past 12\u00a0months was 24.0% (men: 27.5%; women: 21.0%). These proportions were higher among older adults in poor health for five health status indicators but lower among those with less functional capabilities for the three corresponding indicators. Relative to older adults with no morbidity or medication use, any cancer screening was more common in those with multimorbidity (aPR for two\u2013three morbidities: 1.40, 95% CI: 1.10\u20131.79; four or more morbidities: 1.66, 95% CI: 1.19\u20132.31) and polypharmacy (aPR: 1.54, 95% CI: 1.02\u20132.33).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Cancer screening is common among older adults in poor health with multimorbidity and polypharmacy. Our findings reiterate the importance of expanding evidence on personalized approaches to cancer screening among older adults.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11606-025-10037-3","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T16:02:14Z","timestamp":1768233734000},"page":"2498-2506","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cancer Screening Among Older Adults Above 75\u00a0Years of Age According to Health Status: A Population-Based Study"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6034-2300","authenticated-orcid":false,"given":"Frerik","family":"Smit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axelle","family":"Braggion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Gastens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saman","family":"Khalatbari-Soltani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Cullati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Chiolero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"issue":"6","key":"10037_CR1","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.mcna.2020.08.002","volume":"104","author":"AA Kotwal","year":"2020","unstructured":"Kotwal AA, Walter LC. Cancer Screening in Older Adults: Individualized Decision-Making and Communication Strategies. Med Clin North Am. 2020;104(6):989\u20131006. https:\/\/doi.org\/10.1016\/j.mcna.2020.08.002","journal-title":"Med Clin North Am."},{"issue":"4","key":"10037_CR2","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/PPO.0000000000000274","volume":"23","author":"AA Kotwal","year":"2017","unstructured":"Kotwal AA, Schonberg MA. Cancer Screening in the Elderly: A Review of Breast, Colorectal, Lung, and Prostate Cancer Screening. Cancer J. 2017;23(4):246\u2013253. https:\/\/doi.org\/10.1097\/PPO.0000000000000274","journal-title":"Cancer J."},{"key":"10037_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2022.107395","volume":"167","author":"S Rintala","year":"2023","unstructured":"Rintala S, Dahlstrom KR, Franco EL, Louvanto K. A synthesis of evidence for cancer-specific screening interventions: A Preventive Medicine Golden Jubilee Review. Prev Med. 2023;167:107395. https:\/\/doi.org\/10.1016\/j.ypmed.2022.107395","journal-title":"Prev Med."},{"key":"10037_CR4","unstructured":"European Commission. Directorate General for Research and Innovation., European Commission Group of Chief Scientific Advisors. Cancer Screening in the European Union. Publications Office; 2022.\u00a0https:\/\/data.europa.eu\/doi\/10.2777\/867180\u00a0Accessed 24 Jan 2025."},{"key":"10037_CR5","unstructured":"Produits, outils et formations. EviPrev.\u00a0https:\/\/eviprev.ch\/fr\/produits-fr\/ Accessed 12 Aug 2025."},{"issue":"10456","key":"10037_CR6","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/S0140-6736(24)01688-X","volume":"404","author":"A Chiolero","year":"2024","unstructured":"Chiolero A. Low-value population screening. The Lancet. 2024;404(10456):935. https:\/\/doi.org\/10.1016\/S0140-6736(24)01688-X","journal-title":"The Lancet."},{"issue":"4","key":"10037_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.5694\/mja14.01664","volume":"203","author":"IA Scott","year":"2015","unstructured":"Scott IA, Duckett SJ. In search of professional consensus in defining and reducing low\u2010value care. Med J Aust. 2015;203(4):179\u2013181. https:\/\/doi.org\/10.5694\/mja14.01664","journal-title":"Med J Aust."},{"issue":"1","key":"10037_CR8","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1186\/s12889-025-22848-4","volume":"25","author":"F Smit","year":"2025","unstructured":"Smit F, Jolidon V, Van Der Linden BW, Rodondi N, Cullati S, Chiolero A. Cancer screening outside of age recommendations: a population-based study. BMC Public Health. 2025;25(1):1660. https:\/\/doi.org\/10.1186\/s12889-025-22848-4","journal-title":"BMC Public Health."},{"issue":"7","key":"10037_CR9","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.11645","volume":"3","author":"JL Moss","year":"2020","unstructured":"Moss JL, Roy S, Shen C, et al. Geographic Variation in Overscreening for Colorectal, Cervical, and Breast Cancer Among Older Adults. JAMA Netw Open. 2020;3(7):e2011645. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.11645","journal-title":"JAMA Netw Open."},{"issue":"21","key":"10037_CR10","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1001\/jama.285.21.2750","volume":"285","author":"LC Walter","year":"2001","unstructured":"Walter LC, Covinsky KE. Cancer Screening in Elderly Patients: A Framework for Individualized Decision Making. JAMA. 2001;285(21):2750. https:\/\/doi.org\/10.1001\/jama.285.21.2750","journal-title":"JAMA."},{"issue":"24","key":"10037_CR11","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1001\/jama.2013.282612","volume":"310","author":"SJ Lee","year":"2013","unstructured":"Lee SJ, Leipzig RM, Walter LC. Incorporating lag time to benefit into prevention decisions for older adults. JAMA. 2013;310(24):2609\u20132610. https:\/\/doi.org\/10.1001\/jama.2013.282612","journal-title":"JAMA."},{"key":"10037_CR12","doi-asserted-by":"publisher","unstructured":"Lee SJ, Boscardin WJ, Stijacic-Cenzer I, Conell-Price J, O\u2019Brien S, Walter LC. Time lag to benefit after screening for breast and colorectal cancer: meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark. BMJ. 2012;346(jan08 12):e8441-e8441. https:\/\/doi.org\/10.1136\/bmj.e8441","DOI":"10.1136\/bmj.e8441"},{"issue":"2","key":"10037_CR13","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1001\/jama.2011.1966","volume":"307","author":"LC Yourman","year":"2012","unstructured":"Yourman LC, Lee SJ, Schonberg MA, Widera EW, Smith AK. Prognostic indices for older adults: a systematic review. JAMA. 2012;307(2):182\u2013192. https:\/\/doi.org\/10.1001\/jama.2011.1966","journal-title":"JAMA."},{"issue":"1","key":"10037_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13012-022-01247-y","volume":"17","author":"S Ingvarsson","year":"2022","unstructured":"Ingvarsson S, Hasson H, Von Thiele Schwarz U, et al. Strategies for de-implementation of low-value care\u2014a scoping review. Implement Sci. 2022;17(1):73. https:\/\/doi.org\/10.1186\/s13012-022-01247-y","journal-title":"Implement Sci."},{"issue":"7","key":"10037_CR15","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1093\/aje\/kwac056","volume":"191","author":"MP Fox","year":"2022","unstructured":"Fox MP, Murray EJ, Lesko CR, Sealy-Jefferson S. On the Need to Revitalize Descriptive Epidemiology. Am J Epidemiol. 2022;191(7):1174\u20131179. https:\/\/doi.org\/10.1093\/aje\/kwac056","journal-title":"Am J Epidemiol."},{"issue":"9596","key":"10037_CR16","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E Von Elm","year":"2007","unstructured":"Von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. The Lancet. 2007;370(9596):1453\u20131457. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X","journal-title":"The Lancet."},{"key":"10037_CR17","unstructured":"Office f\u00e9d\u00e9ral de la statistique. L\u2019enqu\u00eate suisse sur la sant\u00e9 2022 en bref - Conception, m\u00e9thode, r\u00e9alisation | Publication. Conf\u00e9d\u00e9ration Suisse. 2024.\u00a0https:\/\/www.bfs.admin.ch\/bfs\/fr\/home\/statistiques\/sante\/enquetes\/sgb.assetdetail.31646338.html Accessed 6 Jan 2025."},{"key":"10037_CR18","doi-asserted-by":"publisher","unstructured":"Br\u00e4ndle K, Zwahlen M, Bulliard JL. Breast Cancer Screening Programmes in Switzerland, 2019\u20132021. Centre universitaire de m\u00e9decine g\u00e9n\u00e9rale et sant\u00e9 publique, Lausanne; 2024. https:\/\/doi.org\/10.16908\/ISSN.1660-7104\/356","DOI":"10.16908\/ISSN.1660-7104\/356"},{"key":"10037_CR19","doi-asserted-by":"publisher","first-page":"1608183","DOI":"10.3389\/ijph.2025.1608183","volume":"70","author":"B Albers","year":"2025","unstructured":"Albers B, Auer R, Selby K, Clack L. Organized Colorectal Cancer Screening Programs in Switzerland - Quo Vadis? Int J Public Health. 2025;70:1608183. https:\/\/doi.org\/10.3389\/ijph.2025.1608183","journal-title":"Int J Public Health."},{"key":"10037_CR20","unstructured":"Office f\u00e9d\u00e9ral de la statistique. Enqu\u00eate suisse sur la sant\u00e9 2022 - Questionnaire t\u00e9l\u00e9phonique et \u00e9crit - | Publication. Conf\u00e9d\u00e9ration Suisse. 2024.\u00a0https:\/\/www.bfs.admin.ch\/bfs\/fr\/home\/statistiques\/sante\/enquetes\/sgb.assetdetail.28965077.html Accessed 6 Jan 2025."},{"issue":"9","key":"10037_CR21","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1001\/jama.2013.1184","volume":"309","author":"M Cruz","year":"2013","unstructured":"Cruz M, Covinsky K, Widera EW, Stijacic-Cenzer I, Lee SJ. Predicting 10-Year Mortality for Older Adults. JAMA. 2013;309(9):874. https:\/\/doi.org\/10.1001\/jama.2013.1184","journal-title":"JAMA."},{"issue":"1","key":"10037_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41512-025-00185-9","volume":"9","author":"V Gastens","year":"2025","unstructured":"Gastens V, Chiolero A, Feller M, Bauer DC, Rodondi N, Del Giovane C. Development and internal validation of a new life expectancy estimator for multimorbid older adults. Diagn Progn Res. 2025;9(1):5. https:\/\/doi.org\/10.1186\/s41512-025-00185-9","journal-title":"Diagn Progn Res."},{"issue":"1","key":"10037_CR23","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12889-021-12332-0","volume":"22","author":"H Cho","year":"2022","unstructured":"Cho H, Wang Z, Yabroff KR, et al. Estimating life expectancy adjusted by self-rated health status in the United States: national health interview survey linked to the mortality. BMC Public Health. 2022;22(1):141. https:\/\/doi.org\/10.1186\/s12889-021-12332-0","journal-title":"BMC Public Health."},{"issue":"3","key":"10037_CR24","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/ageing\/afw199","volume":"46","author":"LC Kobayashi","year":"2017","unstructured":"Kobayashi LC, Jackson SE, Lee SJ, Wardle J, Steptoe A. The development and validation of an index to predict 10-year mortality risk in a longitudinal cohort of older English adults. Age Ageing. 2017;46(3):427\u2013432. https:\/\/doi.org\/10.1093\/ageing\/afw199","journal-title":"Age Ageing."},{"issue":"1","key":"10037_CR25","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/eurpub\/cky098","volume":"29","author":"MC Johnston","year":"2019","unstructured":"Johnston MC, Crilly M, Black C, Prescott GJ, Mercer SW. Defining and measuring multimorbidity: a systematic review of systematic reviews. Eur J Public Health. 2019;29(1):182\u2013189. https:\/\/doi.org\/10.1093\/eurpub\/cky098","journal-title":"Eur J Public Health."},{"issue":"1","key":"10037_CR26","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230. https:\/\/doi.org\/10.1186\/s12877-017-0621-2","journal-title":"BMC Geriatr."},{"key":"10037_CR27","unstructured":"Cancer Screening Overview - NCI. January 13, 2010.\u00a0https:\/\/www.cancer.gov\/about-cancer\/screening\/patient-screening-overview-pdq Accessed 8 April 2025."},{"issue":"1","key":"10037_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12874-018-0519-5","volume":"18","author":"W Chen","year":"2018","unstructured":"Chen W, Qian L, Shi J, Franklin M. Comparing performance between log-binomial and robust Poisson regression models for estimating risk ratios under model misspecification. BMC Med Res Methodol. 2018;18(1):63. https:\/\/doi.org\/10.1186\/s12874-018-0519-5","journal-title":"BMC Med Res Methodol."},{"issue":"2\u20133","key":"10037_CR29","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1177\/0098858817723659","volume":"43","author":"JS Kaufman","year":"2017","unstructured":"Kaufman JS. Statistics, Adjusted Statistics, and Maladjusted Statistics. Am J Law Med. 2017;43(2-3):193\u2013208. https:\/\/doi.org\/10.1177\/0098858817723659","journal-title":"Am J Law Med."},{"issue":"9","key":"10037_CR30","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41416-020-1019-z","volume":"123","author":"S Conroy","year":"2020","unstructured":"Conroy S, Murray EJ. Let the question determine the methods: descriptive epidemiology done right. Br J Cancer. 2020;123(9):1351\u20131352. https:\/\/doi.org\/10.1038\/s41416-020-1019-z","journal-title":"Br J Cancer."},{"issue":"3","key":"10037_CR31","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1093\/eurpub\/ckac032","volume":"32","author":"HAR Jensen","year":"2022","unstructured":"Jensen HAR, Lau CJ, Davidsen M, Feveile HB, Christensen AI, Ekholm O. The impact of non-response weighting in health surveys for estimates on primary health care utilization. Eur J Public Health. 2022;32(3):450\u2013455. https:\/\/doi.org\/10.1093\/eurpub\/ckac032","journal-title":"Eur J Public Health."},{"issue":"1","key":"10037_CR32","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/1471-2458-11-114","volume":"11","author":"D Estoppey","year":"2011","unstructured":"Estoppey D, Paccaud F, Vollenweider P, Marques-Vidal P. Trends in self-reported prevalence and management of hypertension, hypercholesterolemia and diabetes in Swiss adults, 1997-2007. BMC Public Health. 2011;11(1):114. https:\/\/doi.org\/10.1186\/1471-2458-11-114","journal-title":"BMC Public Health."},{"issue":"2","key":"10037_CR33","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S1047-2797(02)00257-0","volume":"13","author":"A Van Loon","year":"2003","unstructured":"Van Loon A. Survey Non-response in the Netherlands Effects on Prevalence Estimates and Associations. Ann Epidemiol. 2003;13(2):105\u2013110. https:\/\/doi.org\/10.1016\/S1047-2797(02)00257-0","journal-title":"Ann Epidemiol."},{"issue":"9","key":"10037_CR34","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/aje\/kwx246","volume":"186","author":"A Fry","year":"2017","unstructured":"Fry A, Littlejohns TJ, Sudlow C, et al. Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population. Am J Epidemiol. 2017;186(9):1026\u20131034. https:\/\/doi.org\/10.1093\/aje\/kwx246","journal-title":"Am J Epidemiol."},{"issue":"7450","key":"10037_CR35","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/497428a","volume":"497","author":"V Hughes","year":"2013","unstructured":"Hughes V. The big fat truth. Nature. 2013;497(7450):428\u2013430. https:\/\/doi.org\/10.1038\/497428a","journal-title":"Nature."},{"issue":"4","key":"10037_CR36","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1158\/1055-9965.EPI-07-2629","volume":"17","author":"GH Rauscher","year":"2008","unstructured":"Rauscher GH, Johnson TP, Cho YI, Walk JA. Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2008;17(4):748\u2013757. https:\/\/doi.org\/10.1158\/1055-9965.EPI-07-2629","journal-title":"Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol."},{"key":"10037_CR37","doi-asserted-by":"publisher","unstructured":"Ulyte A, Wei W, Dressel H, et al. Variation of colorectal, breast and prostate cancer screening activity in Switzerland: Influence of insurance, policy and guidelines. Van Hemelrijck M, ed. PLOS ONE. 2020;15(4):e0231409. https:\/\/doi.org\/10.1371\/journal.pone.0231409","DOI":"10.1371\/journal.pone.0231409"},{"issue":"1","key":"10037_CR38","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S1470-2045(08)70336-X","volume":"10","author":"C Terret","year":"2009","unstructured":"Terret C, Castel-Kremer E, Albrand G, Droz JP. Effects of comorbidity on screening and early diagnosis of cancer in elderly people. Lancet Oncol. 2009;10(1):80\u201387. https:\/\/doi.org\/10.1016\/S1470-2045(08)70336-X","journal-title":"Lancet Oncol."},{"key":"10037_CR39","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.2147\/CIA.S171739","volume":"13","author":"J Demb","year":"2018","unstructured":"Demb J, Akinyemiju T, Allen I, Onega T, Hiatt RA, Braithwaite D. Screening mammography use in older women according to health status: a systematic review and meta-analysis. Clin Interv Aging. 2018;13:1987\u20131997. https:\/\/doi.org\/10.2147\/CIA.S171739","journal-title":"Clin Interv Aging."},{"key":"10037_CR40","doi-asserted-by":"publisher","unstructured":"Advani S, Zhang D, Tammemagi M, et al. Comorbidity Profiles and Lung Cancer Screening among Older Adults: U.S. Behavioral Risk Factor Surveillance System 2017\u20132019. Ann Am Thorac Soc. 2021;18(11):1886\u20131893. https:\/\/doi.org\/10.1513\/AnnalsATS.202010-1276OC","DOI":"10.1513\/AnnalsATS.202010-1276OC"},{"issue":"4","key":"10037_CR41","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1177\/1077558711399580","volume":"68","author":"T Lehnert","year":"2011","unstructured":"Lehnert T, Heider D, Leicht H, et al. Review: health care utilization and costs of elderly persons with multiple chronic conditions. Med Care Res Rev MCRR. 2011;68(4):387\u2013420. https:\/\/doi.org\/10.1177\/1077558711399580","journal-title":"Med Care Res Rev MCRR."},{"issue":"1","key":"10037_CR42","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s40545-023-00665-7","volume":"16","author":"J Barrio-Cortes","year":"2023","unstructured":"Barrio-Cortes J, Benito-S\u00e1nchez B, Villimar-Rodriguez AI, et al. Differences in healthcare service utilization in patients with polypharmacy according to their risk level by adjusted morbidity groups: a population-based cross-sectional study. J Pharm Policy Pract. 2023;16(1):161. https:\/\/doi.org\/10.1186\/s40545-023-00665-7","journal-title":"J Pharm Policy Pract."},{"issue":"1","key":"10037_CR43","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1186\/s12913-024-12093-7","volume":"24","author":"GRL Fraser","year":"2024","unstructured":"Fraser GRL, Lambooij MS, Van Exel J, Ostelo RWJG, Van Harreveld F, De Wit GA. Factors associated with patients\u2019 demand for low-value care: a scoping review. BMC Health Serv Res. 2024;24(1):1656. https:\/\/doi.org\/10.1186\/s12913-024-12093-7","journal-title":"BMC Health Serv Res."},{"issue":"2","key":"10037_CR44","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.gerinurse.2017.08.002","volume":"39","author":"S Musich","year":"2018","unstructured":"Musich S, Wang SS, Ruiz J, Hawkins K, Wicker E. The impact of mobility limitations on health outcomes among older adults. Geriatr Nur (Lond). 2018;39(2):162\u2013169. https:\/\/doi.org\/10.1016\/j.gerinurse.2017.08.002","journal-title":"Geriatr Nur (Lond)."},{"issue":"13","key":"10037_CR45","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1007\/s11606-023-08213-4","volume":"38","author":"J Smith","year":"2023","unstructured":"Smith J, Dodd RH, Gainey KM, et al. Factors Influencing Primary Care Practitioners\u2019 Cancer Screening Recommendations for Older Adults: a Systematic Review. J Gen Intern Med. 2023;38(13):2998\u20133020. https:\/\/doi.org\/10.1007\/s11606-023-08213-4","journal-title":"J Gen Intern Med."},{"issue":"11","key":"10037_CR46","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1001\/jamainternmed.2022.4316","volume":"182","author":"NL Schoenborn","year":"2022","unstructured":"Schoenborn NL, Boyd CM, Pollack CE. Physician Attitudes About Using Life Expectancy to Inform Cancer Screening Cessation in Older Adults-Results From a National Survey. JAMA Intern Med. 2022;182(11):1229\u20131231. https:\/\/doi.org\/10.1001\/jamainternmed.2022.4316","journal-title":"JAMA Intern Med."},{"issue":"4","key":"10037_CR47","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1177\/10775587231153269","volume":"80","author":"LE Brotzman","year":"2023","unstructured":"Brotzman LE, Zikmund-Fisher BJ. Perceived Barriers Among Clinicians and Older Adults Aged 65 and Older Regarding Use of Life Expectancy to Inform Cancer Screening: A Narrative Review and Comparison. Med Care Res Rev MCRR. 2023;80(4):372\u2013385. https:\/\/doi.org\/10.1177\/10775587231153269","journal-title":"Med Care Res Rev MCRR."},{"issue":"17","key":"10037_CR48","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1001\/jama.2023.19803","volume":"330","author":"Harris E. Many Older People Disagree With Life Expectancy-Based Cancer Screening","year":"2023","unstructured":"Harris E. Many Older People Disagree With Life Expectancy\u2013Based Cancer Screening. JAMA. 2023;330(17):1612. https:\/\/doi.org\/10.1001\/jama.2023.19803","journal-title":"JAMA."},{"issue":"11","key":"10037_CR49","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.33406","volume":"4","author":"J Smith","year":"2021","unstructured":"Smith J, Dodd RH, Gainey KM, et al. Patient-Reported Factors Associated With Older Adults\u2019 Cancer Screening Decision-making: A Systematic Review. JAMA Netw Open. 2021;4(11):e2133406. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.33406","journal-title":"JAMA Netw Open."},{"key":"10037_CR50","doi-asserted-by":"publisher","unstructured":"McCartney M, Treadwell J, Maskrey N, Lehman R. Making evidence based medicine work for individual patients. BMJ. Published online May 16, 2016:i2452. https:\/\/doi.org\/10.1136\/bmj.i2452","DOI":"10.1136\/bmj.i2452"},{"issue":"2","key":"10037_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(20)30007-4","volume":"5","author":"A Chiolero","year":"2020","unstructured":"Chiolero A, Rodondi N, Santschi V. High-value, data-informed, and team-based care for multimorbidity. Lancet Public Health. 2020;5(2):e84. https:\/\/doi.org\/10.1016\/S2468-2667(20)30007-4","journal-title":"Lancet Public Health."},{"issue":"3","key":"10037_CR52","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1001\/jamainternmed.2016.8254","volume":"177","author":"TC Hoffmann","year":"2017","unstructured":"Hoffmann TC, Del Mar C. Clinicians\u2019 Expectations of the Benefits and Harms of Treatments, Screening, and Tests: A Systematic Review. JAMA Intern Med. 2017;177(3):407. https:\/\/doi.org\/10.1001\/jamainternmed.2016.8254","journal-title":"JAMA Intern Med."},{"issue":"2","key":"10037_CR53","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1001\/jamainternmed.2014.6016","volume":"175","author":"TC Hoffmann","year":"2015","unstructured":"Hoffmann TC, Del Mar C. Patients\u2019 expectations of the benefits and harms of treatments, screening, and tests: a systematic review. JAMA Intern Med. 2015;175(2):274\u2013286. https:\/\/doi.org\/10.1001\/jamainternmed.2014.6016","journal-title":"JAMA Intern Med."},{"issue":"5","key":"10037_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(25)00093-3","volume":"10","author":"F Smit","year":"2025","unstructured":"Smit F, Braggion A, Chiolero A. Screen no matter the risk? Lancet Public Health. 2025;10(5):e361. https:\/\/doi.org\/10.1016\/S2468-2667(25)00093-3","journal-title":"Lancet Public Health."},{"key":"10037_CR55","unstructured":"A European \u201cshield\u201d against colorectal cancer based on novel, more precise and affordable risk-based screening methods and viable policy pathways | ONCOSCREEN | Projekt | Fact Sheet | HORIZON. CORDIS | European Commission.\u00a0https:\/\/cordis.europa.eu\/project\/id\/101097036 Accessed 14 April 2025."},{"key":"10037_CR56","doi-asserted-by":"publisher","unstructured":"Esserman LJ, The WISDOM Study and Athena Investigators, Anton-Culver H, et al. The WISDOM Study: breaking the deadlock in the breast cancer screening debate. Npj Breast Cancer. 2017;3(1):34. https:\/\/doi.org\/10.1038\/s41523-017-0035-5","DOI":"10.1038\/s41523-017-0035-5"},{"key":"10037_CR57","doi-asserted-by":"publisher","unstructured":"Wang R. Combining Data from Multiple Studies. NEJM Evid. 2023;2(5). https:\/\/doi.org\/10.1056\/EVIDe2300066","DOI":"10.1056\/EVIDe2300066"},{"issue":"1","key":"10037_CR58","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2217\/pme.14.65","volume":"12","author":"KB Brothers","year":"2015","unstructured":"Brothers KB, Rothstein MA. Ethical, legal and social implications of incorporating personalized medicine into healthcare. Pers Med. 2015;12(1):43\u201351. https:\/\/doi.org\/10.2217\/pme.14.65","journal-title":"Pers Med."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-10037-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-025-10037-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-10037-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T16:05:45Z","timestamp":1782403545000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-025-10037-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":58,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10037"],"URL":"https:\/\/doi.org\/10.1007\/s11606-025-10037-3","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"18 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not require formal ethics approval from an ethics committee as regulated by the Federal Statistics Act of 1992 (SR 431.01). Swiss Health Survey data comes in anonymized form, and is carried out by the Swiss Federal Statistical Office in accordance with the regulations of the Ordonnance concernant l\u2019ex\u00e9cution des relev\u00e9s statisiques f\u00e9d\u00e9raux of 1993 (SR 431.012.1) and the Federal Act on the Federal Census of 2008 (SR 431.112). Under these laws, the Swiss Health Survey is permitted to recruit residents of Switzerland aged 15\u00a0years and above without formal written consent. Nevertheless, all individuals invited to participate in the Swiss Health Survey could decline participation and withdraw their participation at any point in time.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Informed Consent"}},{"value":"The authors declare that they do not have a conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}